Refarmed Chemicals, formerly Refarmed Research Pharmaceutique, was founded in the 1970s in Switzerland. With over 40 years of experience, it is a customer-focused active ingredient distributor in the generic pharmaceutical industry. The company is fully integrated from APIs to FDFs and has expertise in the clinical and biological sector. In 2022, Refarmed Chemicals was acquired by DKSH Group, a global Market Expansions Services provider, further strengthening its position in the industry.

Refarmed's integration within the pharmaceutical industry is facilitated through its stakeholding system, which covers various aspects ranging from active pharmaceutical ingredients (APIs) to finished dosage forms (FDFs). This comprehensive approach ensures that Refarmed is well-equipped to serve the industry's demands effectively.

Moreover, Refarmed possesses a rich history in the clinical and biological sector, which serves as a valuable complement to its existing expertise and capabilities.